Request for Free Sample

Biopharma Plastic Market Report Scope & Overview:

The Biopharma Plastic market size was valued at USD 6.07 billion in 2024 and is expected to reach USD 13.35 billion by 2032, growing at a CAGR of 10.37% over the forecast period of 2025-2032.

Growth in the biopharma plastic market is driven by single-use systems, polymer-based drug delivery, and sustainable biopharma materials. In 2025, a major biopharma plastics provider, such as Thermo Fisher Scientific, introduced the single-use 5L DynaDrive bioreactor to push forward the development of plastic-based bioreactors and sterile plastic parts. Biopharma plastic market trends, such as flexible biopharmaceutical packaging, medical plastics, and plastic tubing in pharmaceuticals for fluid management.

Reportedly, more than 140 individuals from 70+ suppliers and end-users have contributed to the biopharma plastic market analysis by providing best practices for disposable bioprocessing at the BPSA 2024's International Single-Use Summit. BPSA again released FAQs and a sustainability one-pager in 2025 to provide direction for biopharmaceutical manufacturing and polymer-based drug delivery solutions. It is the dynamic landscape that is molding the growing size of the biopharma plastic market with innovative biopharmaceutical packaging and disposable bioprocessing solutions designed around the world standard for quality.

Market Dynamics:

Drivers:

  • Surge in Modular Cleanroom Facilities Accelerates Biopharma Plastic Market Growth Globally

The growth of the biopharma plastics market is largely driven by the increase in modular construction of cleanrooms, the rising implementation of single-use technology in biopharma production, and the use of medical-grade plastics. G-CON Manufacturing collaborated with Pfizer to rapidly deploy modular cleanrooms in 2024. This increases the need for plastic bioreactors, plastic tubing for pharma, and sterile plastic components. With biopharmaceutical manufacturing trending towards flexible, smaller lots, biopharma plastic firms see that they have a higher biopharma plastic market share, and biopharma plastic market trends are more and more toward fast and scalable solutions in disposable bioprocessing and biopharmaceutical packaging.

  • Government Funding for Cell and Gene Therapy Scales Biopharma Plastic Market Growth

Increasing government investment drives growth of the biopharma plastic market and fills in the biopharma plastic market size. In June 2024, NIH committed more than $100 million to support cell and gene therapy manufacturing. This trend stimulates the demand for single-use systems, plastic bioreactors, and specialized polymer-based drug delivery. Biopharma plastic enterprises are strong market share of biopharma plastic more and more, and biopharmaceutical packaging requirements are increasing with the scale of production. This trend bodes well for continued biopharma plastic market examination and growth of the disposable bioprocessing and medical-grade plastics markets.

Restraints:

  • Fluctuating Energy Prices Increase Production Costs in Biopharma Plastic Manufacturing, Impeding Market Expansion

The biopharma plastic market size is significantly influenced by volatile energy prices, which increase the production price of medical-grade plastic and disposable bioprocessing products. Industrial electricity prices in the U.S. were 12% higher YoY in 2025, as per the U.S. EIA reports. Competitive pressures force biopharma plastic firms to strike a balance between cost pressures and the costs associated with polymer for drug delivery systems, plastics for bioreactors, and the packaging used by the biopharmaceutical industry. This sort of volatility makes analyzing the biopharma plastic market challenging and constraining the biopharma plastic market growth, as producers must adjust to cost fluctuations when satisfying worldwide demand.

Segmentation Analysis:

By Material Type

Polypropylene (PP) dominated the Biopharma Plastic Market in 2024 with a 32.40% share due to exceptional chemical resistance and sterilization compatibility. PP, which complies with FDA cleanroom requirements and can withstand gamma sterilization, is commonly applied for disposable bioprocessing and polymer drug delivery. Demand is on the rise in the pharmaceutical plastic tubing and sterile plastic components used in large-scale biopharmaceutical production, according to SABIC. This trend, supported by biopharma plastic companies, strengthens biopharma plastic market share and is in line with the global shifts toward secure, one-time-use technology and biopharma packaging.

Polytetrafluoroethylene (PTFE) is the fastest-growing in the biopharma plastic market with a CAGR of 12.25% during the forecast period of 2025-2032, due to high-purity single-use systems being over demand. With its super chemical resistance, PTFE is the optimal material for high-demanding pharmaceutical plastic tubing and plastic bioreactors for advanced therapies. NIH's 2024 USD 100 million investment toward cell and gene therapy manufacturing has increased its uptake of it, subsequently increasing the biopharma plastic market size. PTFE's application aids the demand for complex biopharma materials, as it improves the performance of sterile plastic components and drives trends in the future biopharma plastic market.

By Product Type

Tubing dominated the Biopharma Plastic Market in 2024 with a 28.70% share, owing to its critical need for single-use systems. Spun from plastic bioreactors, depth filters, and polymer-based drug delivery components are linked by flexible tubing, allowing for aseptic flow of fluids. Demand jumped significantly with the shift of biopharmaceutical production to disposable bioprocessing, which contributed to the strong market share in the biopharma plastic category, according to Saint-Gobain Performance Plastics. This product category continues to be a staple among biopharma plastic suppliers, in line with industry demand for contamination control and scalable biopharma packaging.

Films & bags are the fastest growing in the biopharma plastic market with a CAGR of 11.21% during the forecast period of 2025-2032, due to the increased use of flexible bioreactors for folding purposes. Their development facilitates production at lower cost and scalability in cell therapy manufacturing. Thermo Fisher Scientific increased single-use bioreactor film production in 2024 to meet the demand. These medical-grade plastics provide operational flexibility, minimize cleaning validation, and are compatible with global biopharma plastic market analysis predicting strong growth of sterile plastic components and disposable bioprocessing products.

By Application

Containers dominated the biopharma plastic market in 2024 with a 27.40% share on account of their essential usage in sterile storage and sampling. They are used as a component of polymer-based drug delivery and within biopharmaceutical packaging to ensure the safe handling of the product. Gerresheimer AG reported that there was a rising demand for robust, compliant containers. This trend fuels investments made by biopharma plastic companies and ensures a steady biopharma plastic market share in the production and storage of biologics and advanced therapies.

Bioreactor bags are the fastest-growing in the biopharma plastic market with a CAGR of 11.60% during the forecast period of 2025-2032, driven by scalable manufacturing demand from cell and gene therapy production. These soft systems are easier on the upstream process and allow for lower cleaning and expense than the stainless-steel alternative. NIH’s 2024 investment of USD 100 million super-charged adoption; biopharma plastic market share trends reflected this change. Biopharma plastic companies meet demand with faster production with single-use bioreactor bags from medical-grade plastics.

By End-use

Pharmaceutical & biotechnology companies dominated the Biopharma Plastic Market in 2024 with a 52.60% share due to investment by the pharmaceutical & biotechnology companies in large-scale production of biologics. Their inclination toward disposable systems, plastic bioreactors, and polymer-based drug delivery systems escalates the market share for biopharma plastics. Growth in Pfizer capacity underscores demand for sterile plastic parts and compliant biopharma packaging. This is also consistent with analyses of the biopharma plastic market that innovation and ubiquitous production are likely to be the driving forces of market expansion.

Contract manufacturing organizations (CMOs) are the fastest growing in the biopharma plastic market with a CAGR of 11.03% during the forecast period of 2025-2032, as attributed to outsourcing in the advanced therapies. Smaller biotechs are increasingly dependent on CMOs for scaling up their viral vector and gene therapy production. Catalent’s involvement in gene therapy manufacturing is indicative of this burgeoning scale, driving demand for disposable bioprocessing equipment and medical plastics. This is in line with the demand for biopharma plastic, which then promotes greater flexibility and more regulatory compliance for biopharma plastic companies.

Regional Analysis:

North America dominated the Biopharma Plastic Market in 2024 with a significant market share of 36.80% driven by the presence of a well-established biotechnology industry and the presence of a solid supporting industrial infrastructure. Biopharma plastic manufacturers in the U.S. enjoy mature regulatory environments, and sophisticated manufacturing requirements are resulting in demand for medical-grade plastics and sterile plastic parts. Local bioprocessing tubing expansion meets increased demand for biologics, says Saint-Gobain Performance Plastics. Additionally, a developing biopharmaceutical packaging industry in Canada further bolsters the biopharma plastic market share in the region and is a key driver for the growth of the biopharma plastic market.

The U.S. dominates North America’s Biopharma Plastic Market with a size of USD 1.84 billion in 2024 and is projected to reach a market size of USD 4.01 billion by 2032 with a market share of about 82%, supported by significant investment in polymer-based drug delivery and large-scale biopharmaceuticals manufacturing facilities. In 2024, Pfizer revealed major facility enlargements for the production of single-use systems and plastic-based bioreactors. The FDA’s guidance on current good manufacturing practice (cGMP) pushes the use of high-performance medical-grade plastics even more in pharmaceutical plastic tubing and disposable bioprocessing. Continued by this regulatory-backed innovation and infrastructure, this also propelled the U.S. share in the biopharma plastic market size, keeping them the front runners even in the domain of biopharma plastic market analysis.

Asia Pacific is the fastest-growing region with the highest CAGR of 10.87% during the forecast period of 2025-2032, with a growth in biopharma plastic companies and an increase in biopharmaceutical manufacturing capacity in the economically developing countries, including China, India, and Japan. Polymer-based drug delivery and disposable systems are promoted by government programs, including China’s 14th Five-Year Plan to drive domestic production. An expanding contract manufacturing market in India increases the disposable bioprocessing potential. Meanwhile, in Japan, investment in future-proof pharmaceutical plastic tubing technologies in Japan is gathering pace. This rapid evolution lifts the Biopharma Plastic Market Trends and infuses the market with intensely developing trends.

Key Players:

The major biopharma plastic market competitors include Thermo Fisher Scientific Inc., Saint-Gobain Performance Plastics, West Pharmaceutical Services, Inc., Gerresheimer AG, Stevanato Group, Nemera, AptarGroup, Tekni-Plex, Inc., Berry Global Inc., SiO2 Medical Products, Ompi s.r.l., Spectrum Plastics Group, Catalent, Inc., Schott AG, Bormioli Pharma S.p.A., W. L. Gore & Associates, Inc., Plastipak Holdings, Inc., Tekni-Plex Healthcare, Freudenberg Medical, and Entegris, Inc.

Recent Developments:

  • In June 2025, West Pharmaceutical Services inaugurated an advanced 18,000 m² manufacturing facility in Singapore to produce high‑precision single‑use system components and sterile plastic parts.

  • In April 2025, Thermo Fisher Scientific introduced the 5 L DynaDrive single‑use bioreactor, enhancing process development efficiency and environmental sustainability in plastic‑based bioreactors.

Biopharma Plastic Market Report Scope:
Report Attributes Details
Market Size in 2024 USD 6.07 billion
Market Size by 2032 USD 13.35 billion
CAGR CAGR of 10.37% From 2025 to 2032
Base Year 2024
Forecast Period 2025-2032
Historical Data 2021-2023
Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments •By Material Type (Polyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), and Others)
•By Product Type (Bottles & Containers, Tubing, Connectors, Films & Bags, Syringes & Cartridges, and Others)
•By Application (Protective Wear, Containers, Bioreactor Bags, Syringes, Depth Filters, Disposable Medical Connectors, and Others)
•By End-use (Pharmaceutical & Biotechnology Companies, Contract Manufacturing Organizations (CMOs), Research & Academic Laboratories, Clinical & Diagnostic Labs, and Others)
Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Thermo Fisher Scientific Inc., Saint-Gobain Performance Plastics, West Pharmaceutical Services, Inc., Gerresheimer AG, Stevanato Group, Nemera, AptarGroup, Tekni-Plex, Inc., Berry Global Inc., SiO2 Medical Products, Ompi s.r.l., Spectrum Plastics Group, Catalent, Inc., Schott AG, Bormioli Pharma S.p.A., W. L. Gore & Associates, Inc., Plastipak Holdings, Inc., Tekni-Plex Healthcare, Freudenberg Medical, and Entegris, Inc.

Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032

 2.3 Market Size & Forecast, By Segmentation, 2021–2032

  2.3.1 Market Size By Material Type

         2.3.2 Market Size By Product Type

  2.3.3 Market Size By Application

         2.3.4 Market Size By End-use

 2.4 Market Share & Bps Analysis By Region, 2024

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

 4.1 Raw Material Sourcing Trends

  4.1.1 Overview

  4.1.2 Regional sourcing share of glycerol derivatives

         4.1.3 Imports vs. local production of glycerol

         4.1.4 Impact of bio-based glycerol feedstocks

 4.2 Demand in Plant-Based Food Sector

  4.2.1 Overview

  4.2.2 Use in dairy alternatives and vegan spreads

  4.2.3 Growth in plant-based meat Product Types

         4.2.4 Regulatory approvals for clean-label additives

 4.3 Regulatory Approvals by Region

  4.3.1 Overview

  4.3.2 FDA approvals for food emulsifiers usage

  4.3.3 European Commission (EU) approvals and updates

  4.3.4 National regulations in China and Japan

5. Biopharma Plastic Market Segmental Analysis & Forecast, By Material Type, 2021 – 2032, Value (USD Billion) & Volume (Kilotons)

5.1 Introduction

 5.2 Polyethylene (PE)

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2021 – 2032

 5.3 Polypropylene (PP)

  5.3.1 Key Trends

  5.3.2 Market Size & Forecast, 2021 – 2032

 5.4 Acrylonitrile Butadiene Styrene (ABS)

  5.4.1 Key Trends

  5.4.2 Market Size & Forecast, 2021 – 2032

 5.5 Polyethylene Terephthalate (PET)

  5.5.1 Key Trends

  5.5.2 Market Size & Forecast, 2021 – 2032

 5.6 Polyvinyl Chloride (PVC)

  5.6.1 Key Trends

  5.6.2 Market Size & Forecast, 2021 – 2032

 5.7 Polytetrafluoroethylene (PTFE)

  5.7.1 Key Trends

  5.7.2 Market Size & Forecast, 2021 – 2032

 5.8 Polycarbonate (PC)

  5.8.1 Key Trends

  5.8.2 Market Size & Forecast, 2021 – 2032

 5.9 Others

  5.9.1 Key Trends

  5.9.2 Market Size & Forecast, 2021 – 2032

6. Biopharma Plastic Market Segmental Analysis & Forecast, By Product Type, 2021 – 2032, Value (USD Billion) & Volume (Kilotons)

    6.1 Introduction

 6.2 Bottles & Containers

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2021 – 2032

 6.3 Tubing

  6.3.1 Key Trends

  6.3.2 Market Size & Forecast, 2021 – 2032

 6.4 Connectors

  6.4.1 Key Trends

  6.4.2 Market Size & Forecast, 2021 – 2032

 6.5 Films & Bags

  6.5.1 Key Trends

  6.5.2 Market Size & Forecast, 2021 – 2032

 6.6 Syringes & Cartridges

  6.6.1 Key Trends

  6.6.2 Market Size & Forecast, 2021 – 2032

 6.7 Others

  6.7.1 Key Trends

  6.7.2 Market Size & Forecast, 2021 – 2032

7. Biopharma Plastic Market Segmental Analysis & Forecast, By Application, 2021 – 2032, Value (USD Billion) & Volume (Kilotons)

    7.1 Introduction

 7.2 Protective Wear

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2021 – 2032

 7.3 Containers

  7.3.1 Key Trends

  7.3.2 Market Size & Forecast, 2021 – 2032

 7.4 Bioreactor Bags

  7.4.1 Key Trends

  7.4.2 Market Size & Forecast, 2021 – 2032

 7.5 Syringes

  7.5.1 Key Trends

  7.5.2 Market Size & Forecast, 2021 – 2032

 7.6 Depth Filters

  7.6.1 Key Trends

  7.6.2 Market Size & Forecast, 2021 – 2032

 7.7 Disposable Medical Connectors

  7.7.1 Key Trends

  7.7.2 Market Size & Forecast, 2021 – 2032

 7.8 Others

  7.8.1 Key Trends

  7.8.2 Market Size & Forecast, 2021 – 2032

8. Biopharma Plastic Market Segmental Analysis & Forecast, By End-use, 2021 – 2032, Value (USD Billion) & Volume (Kilotons)

    8.1 Introduction

 8.2 Pharmaceutical & Biotechnology Companies

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2021 – 2032

 8.3 Contract Manufacturing Organizations (CMOs)

  8.3.1 Key Trends

  8.3.2 Market Size & Forecast, 2021 – 2032

 8.4 Research & Academic Laboratories

  8.4.1 Key Trends

  8.4.2 Market Size & Forecast, 2021 – 2032

 8.5 Clinical & Diagnostic Labs

  8.5.1 Key Trends

  8.5.2 Market Size & Forecast, 2021 – 2032

 8.6 Others

9. Biopharma Plastic Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion) & Volume (Kilotons)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

 9.2.3 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

 9.2.4 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

 9.2.5 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

 9.2.6 Biopharma Plastic Market Size & Forecast, By Country, 2021 – 2032

  9.2.6.1 USA

   9.2.6.1.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.2.6.1.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.2.6.1.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.2.6.1.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.2.6.2 Canada

   9.2.6.2.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.2.6.2.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.2.6.2.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.2.6.2.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

 9.3.3 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

 9.3.4 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

 9.3.5 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

 9.3.6 Biopharma Plastic Market Size & Forecast, By Country, 2021 – 2032

  9.3.6.1 Germany

   9.3.6.1.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.3.6.1.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.3.6.1.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.3.6.1.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.3.6.2 UK

   9.3.6.2.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.3.6.2.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.3.6.2.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.3.6.2.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.3.6.3 France

   9.3.6.3.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.3.6.3.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.3.6.3.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.3.6.3.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.3.6.4 Italy

   9.3.6.4.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.3.6.4.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.3.6.4.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.3.6.4.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.3.6.5 Spain

   9.3.6.5.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.3.6.5.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.3.6.5.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.3.6.5.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.3.6.6 Russia

   9.3.6.6.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.3.6.6.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.3.6.6.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.3.6.6.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.3.6.7 Poland

   9.3.6.7.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.3.6.7.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.3.6.7.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.3.6.7.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.3.6.8 Rest of Europe

   9.3.6.8.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.3.6.8.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.3.6.8.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.3.6.8.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032   

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

 9.4.3 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

 9.4.4 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

 9.4.5 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

 9.4.6 Biopharma Plastic Market Size & Forecast, By Country, 2021 – 2032

  9.4.6.1 China

   9.4.6.1.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.4.6.1.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.4.6.1.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.4.6.1.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.4.6.2 India

   9.4.6.2.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.4.6.2.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.4.6.2.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.4.6.2.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.4.6.3 Japan

   9.4.6.3.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.4.6.3.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.4.6.3.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.4.6.3.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.4.6.4 South Korea

   9.4.6.4.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.4.6.4.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.4.6.4.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.4.6.4.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.4.6.5 Australia

   9.4.6.5.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.4.6.5.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.4.6.5.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.4.6.5.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.4.6.6 ASEAN Countries

   9.4.6.6.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.4.6.6.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.4.6.6.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.4.6.6.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.4.6.7 Rest of Asia-Pacific

   9.4.6.7.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.4.6.7.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.4.6.7.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.4.6.7.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

 9.5.3 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

 9.5.4 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

 9.5.5 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

 9.5.6 Biopharma Plastic Market Size & Forecast, By Country, 2021 – 2032

  9.5.6.1 Brazil

   9.5.6.1.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.5.6.1.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.5.6.1.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.5.6.1.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.5.6.2 Argentina

   9.5.6.2.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.5.6.2.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.5.6.2.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.5.6.2.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.5.6.3 Mexico

   9.5.6.3.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.5.6.3.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.5.6.3.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.5.6.3.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.5.6.4 Colombia

   9.5.6.4.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.5.6.4.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.5.6.4.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.5.6.4.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.5.6.5 Rest of Latin America

   9.5.6.5.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.5.6.5.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.5.6.5.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.5.6.5.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

 9.6.3 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

 9.6.4 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

 9.6.5 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

 9.6.6 Biopharma Plastic Market Size & Forecast, By Country, 2021 – 2032

  9.6.6.1 UAE

   9.6.6.1.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.6.6.1.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.6.6.1.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.6.6.1.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.6.6.2 Saudi Arabia

   9.6.6.2.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.6.6.2.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.6.6.2.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.6.6.2.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.6.6.3 Qatar

   9.6.6.3.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.6.6.3.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.6.6.3.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.6.6.3.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.6.6.4 Egypt

   9.6.6.4.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.6.6.4.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.6.6.4.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.6.6.4.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.6.6.5 South Africa

   9.6.6.5.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.6.6.5.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.6.6.5.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.6.6.5.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

  9.6.6.6 Rest of Middle East & Africa

   9.6.6.6.1 Biopharma Plastic Market Size & Forecast, By Material Type, 2021 – 2032

   9.6.6.6.2 Biopharma Plastic Market Size & Forecast, By Product Type, 2021 – 2032

   9.6.6.6.3 Biopharma Plastic Market Size & Forecast, By Application, 2021 – 2032

   9.6.6.6.4 Biopharma Plastic Market Size & Forecast, By End-use, 2021 – 2032

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2024

  10.2.2 Year-Wise Strategies & Development, 2021 – 2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2024

 10.3 Market Share Analysis, 2024

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

 10.6 Key Company Profiles

10.6 Key Company Profiles

 10.6.1 Thermo Fisher Scientific Inc.

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Product/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

 10.6.2 Saint-Gobain Performance Plastics

  10.6.2.1 Company Overview & Snapshot

  10.6.2.2 Product/Service Portfolio

  10.6.2.3 Key Company Financials

  10.6.2.4 SWOT Analysis

 10.6.3 West Pharmaceutical Services, Inc.

  10.6.3.1 Company Overview & Snapshot

  10.6.3.2 Product/Service Portfolio

  10.6.3.3 Key Company Financials

  10.6.3.4 SWOT Analysis

 10.6.4 Gerresheimer AG

  10.6.4.1 Company Overview & Snapshot

  10.6.4.2 Product/Service Portfolio

  10.6.4.3 Key Company Financials

  10.6.4.4 SWOT Analysis

 10.6.5 Stevanato Group

  10.6.5.1 Company Overview & Snapshot

  10.6.5.2 Product/Service Portfolio

  10.6.5.3 Key Company Financials

  10.6.5.4 SWOT Analysis

 10.6.6 Nemera

  10.6.6.1 Company Overview & Snapshot

  10.6.6.2 Product/Service Portfolio

  10.6.6.3 Key Company Financials

  10.6.6.4 SWOT Analysis

 10.6.7 AptarGroup

  10.6.7.1 Company Overview & Snapshot

  10.6.7.2 Product/Service Portfolio

  10.6.7.3 Key Company Financials

  10.6.7.4 SWOT Analysis

 10.6.8 Tekni-Plex, Inc.

  10.6.8.1 Company Overview & Snapshot

  10.6.8.2 Product/Service Portfolio

  10.6.8.3 Key Company Financials

  10.6.8.4 SWOT Analysis

 10.6.9 Berry Global Inc.

  10.6.9.1 Company Overview & Snapshot

  10.6.9.2 Product/Service Portfolio

  10.6.9.3 Key Company Financials

  10.6.9.4 SWOT Analysis

 10.6.10 SiO2 Medical Products

  10.6.10.1 Company Overview & Snapshot

  10.6.10.2 Product/Service Portfolio

  10.6.10.3 Key Company Financials

  10.6.10.4 SWOT Analysis

 10.6.11 Ompi s.r.l.

  10.6.11.1 Company Overview & Snapshot

  10.6.11.2 Product/Service Portfolio

  10.6.11.3 Key Company Financials

  10.6.11.4 SWOT Analysis

 10.6.12 Spectrum Plastics Group

  10.6.12.1 Company Overview & Snapshot

  10.6.12.2 Product/Service Portfolio

  10.6.12.3 Key Company Financials

  10.6.12.4 SWOT Analysis

 10.6.13 Catalent, Inc.

  10.6.13.1 Company Overview & Snapshot

  10.6.13.2 Product/Service Portfolio

  10.6.13.3 Key Company Financials

  10.6.13.4 SWOT Analysis

 10.6.14 Schott AG

  10.6.14.1 Company Overview & Snapshot

  10.6.14.2 Product/Service Portfolio

  10.6.14.3 Key Company Financials

  10.6.14.4 SWOT Analysis

 10.6.15 Bormioli Pharma S.p.A.

  10.6.15.1 Company Overview & Snapshot

  10.6.15.2 Product/Service Portfolio

  10.6.15.3 Key Company Financials

  10.6.15.4 SWOT Analysis

 10.6.16 W. L. Gore & Associates, Inc.

  10.6.16.1 Company Overview & Snapshot

  10.6.16.2 Product/Service Portfolio

  10.6.16.3 Key Company Financials

  10.6.16.4 SWOT Analysis

 10.6.17 Plastipak Holdings, Inc.

  10.6.17.1 Company Overview & Snapshot

  10.6.17.2 Product/Service Portfolio

  10.6.17.3 Key Company Financials

  10.6.17.4 SWOT Analysis

 10.6.18 Tekni-Plex Healthcare

  10.6.18.1 Company Overview & Snapshot

  10.6.18.2 Product/Service Portfolio

  10.6.18.3 Key Company Financials

  10.6.18.4 SWOT Analysis

 10.6.19 Freudenberg Medical

  10.6.19.1 Company Overview & Snapshot

  10.6.19.2 Product/Service Portfolio

  10.6.19.3 Key Company Financials

  10.6.19.4 SWOT Analysis

 10.6.20 Entegris, Inc.

  10.6.20.1 Company Overview & Snapshot

  10.6.20.2 Product/Service Portfolio

  10.6.20.3 Key Company Financials

  10.6.20.4 SWOT Analysis

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions On Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures

Key Segments: 

By Material Type

  • Polyethylene (PE)

  • Polypropylene (PP)

  • Acrylonitrile Butadiene Styrene (ABS)

  • Polyethylene Terephthalate (PET)

  • Polyvinyl Chloride (PVC)

  • Polytetrafluoroethylene (PTFE)

  • Polycarbonate (PC)

  • Others

By Product Type

  • Bottles & Containers

  • Tubing

  • Connectors

  • Films & Bags

  • Syringes & Cartridges

  • Others

By Application

  • Protective Wear

  • Containers

  • Bioreactor Bags

  • Syringes

  • Depth Filters

  • Disposable Medical Connectors

  • Others

By End-use

  • Pharmaceutical & Biotechnology Companies

  • Contract Manufacturing Organizations (CMOs)

  • Research & Academic Laboratories

  • Clinical & Diagnostic Labs

  • Others

Request for Segment Customization as per your Business Requirement: Segment Customization Request

Regional Coverage: 

North America

  • US

  • Canada

  • Mexico

Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Poland

  • Turkey

  • Rest of Europe

Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Singapore

  • Australia

  • Rest of Asia Pacific

Middle East & Africa

  • UAE

  • Saudi Arabia

  • Qatar

  • South Africa

  • Rest of Middle East & Africa

Latin America

  • Brazil

  • Argentina

  • Rest of Latin America

Request for Country Level Research Report: Country Level Customization Request

Available Customization 

With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report: 

  • Detailed Volume Analysis 

  • Criss-Cross segment analysis (e.g. Product X Application) 

  • Competitive Product Benchmarking 

  • Geographic Analysis 

  • Additional countries in any of the regions 

  • Customized Data Representation 

  • Detailed analysis and profiling of additional market players

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

 

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.